Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 1094

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 1094
---
1**Form of Proxy Card of TuHURA Biosciences, Inc.99.2**Form of Proxy Card of Kineta, Inc.101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.101.SCHInline XBRL Taxonomy Extension Schema Document101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document101.LABInline XBRL Taxonomy Extension Label Linkbase Document101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document104*Cover Page Interactive Data File (embedded within the Inline XBRL document)107*Filing fee table†Confidential treatment is requested for certain confidential portions of this exhibit pursuant to Rule24b-2under the Exchange Act. In accordance with Rule24b-2,these confidential portions have been omitted from this exhibit and filed separately with the Securities and Exchange Commission.II-5
| †† | Schedule has been omitted pursuant to Item 601(a)(5) of Regulation S-K. TuHURA hereby undertakes to furnish copies of any of the omitted schedules upon request by the Securities and Exchange Commission. |

| * | Filed herewith. |

| ** | To be filed by amendment. |

| *** | Previously filed. |

| 

# | Indicates management contract or compensatory plan or arrangement. |
Item 22. Undertakings The undersigned registrant hereby undertakes:

| A. | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set